[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_95":96},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":18,"_19":20,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":29,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":-5,"_46":47,"_48":-5,"_49":-5,"_50":51,"_52":53,"_54":55,"_56":57,"_58":57,"_59":60,"_61":40,"_62":63},"id","cbtqdgwjxd000gwntmhrqt7vi","revision",2,"title","Biophytis S.A. 提交 6-K，附上 2026 年上半年业绩及战略更新新闻稿","originalTitle","6-K - Biophytis SA (0001768946) (Filer)","summary","Biophytis S.A. 于 11 月 2 日向 SEC 提交 6-K，说明公司已于 10 月 30 日发布 2026 年上半年业绩并更新战略的新闻稿。该新闻稿作为附件 99.1 随文件提交。","reason","source",{"_11":85,"_86":87,"_88":89,"_90":57,"_91":92,"_93":94},"links",{"_82":83,"_63":84},"publishedAt","2026-11-02T13:14:05.000Z","discoveredAt","2026-11-03T04:44:15.621Z","timelineAt","category","ai-products","tags",[80,81],"stockSymbols",[],"score",18,"selected",false,"channel","news","story",{"_72":73,"_15":74},"x","readingMode","full","author","language","body",{"_76":-5,"_63":77,"_78":-5,"_79":40},"outline",[],"relatedStories",[75],"indexable",true,"markdownAvailable","group",{"_64":65,"_43":66,"_67":68,"_69":70,"_71":70},"hasTranslation","bodyLanguage","original","factId","fVyAehkXGtGM",{"_72":73,"_15":74},"reportCount",1,"additionalSourceCount",0,"developmentCount","publicId","604e3570-b740-46b6-9f4a-da46de1480fb","Biophytis披露2026年上半年业绩及半年度报告",{"_72":73,"_15":74},"zh","

UNITED STATES SECURITIES

AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date of report: November 2, 2026

Commission File Number: 001-38974

BIOPHYTIS S.A.

(Translation of registrant’s name into\nEnglish)

Stanislas Veillet
\nBiophytis S.A.

Silver Innov

54 rue Molière

94200 Ivry sur Seine, France

+33 1 76 28 40 83

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual\nreports under cover of Form 20-F or Form 40-F:

x Form\n20-F ¨ Form 40-F

Indicate\nby check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate\nby check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

On October 30, 2026, Biophytis S.A. issued a press release announcing\nthe report of First-Half 2026 results and providing an update on its strategy. A copy of the press release is attached as Exhibit 99.1\nto this Form 6-K.

EXHIBIT LIST

\n \n \n \n \n \n \n \n \n

Exhibit		Description
99.1		Press Release dated\n October30, 2026.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n

	BIOPHYTIS S.A.

Date: November 2, 2026	By:	/s/ Stanislas Veillet
		Name: Stanislas Veillet
		Title: Chairman and Chief Executive Officer

","zhKind","complete","公司与财报","财报","aihot","/items/cbtqdgwjxd000gwntmhrqt7vi","https://www.sec.gov/Archives/edgar/data/1768946/000110465926120945/0001104659-26-120945-index.htm","rss-sec-xbrl","name","SEC · EDGAR 财务披露","kind","rss","firstParty","iconUrl","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar&exp=1794873600&sig=187d1741eb567c1f","iconSrcSet","/api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-48&exp=1794873600&sig=bf6a936df2e54c4a 48w, /api/img-proxy?u=https%3A%2F%2Fwww.sec.gov%2Fthemes%2Fcustom%2Fuswds_sec%2Fassets%2Fimg%2Ffavicons%2Fapple-touch-icon.png&mode=avatar-96&exp=1794873600&sig=732799f81e0d268a 96w","changelogVersion","2026-10-01T08:00"]